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Abstract
Background: To study the relationship between endoscopic practice and adverse events during colonoscopy
under standard deep sedation induced and monitored by an anesthetist.
Methods: We investigated the routine activity of an endoscopy center at the Padova University teaching hospital.
We considered not only endoscopic and cardiorespiratory complications, but also the need to use high-dose
propofol to complete the procedure, and the inability to complete the procedure. Variables relating to the patient’s
clinical conditions, bowel preparation, the endoscopist’s and the anesthetist’s experience, and the duration of the
procedure were input in the model.
Results: 617 procedures under deep sedation were performed with a 5% rate of adverse events. The average dose
of propofol used was 2.6±1.2 mg/kg. In all, 14 endoscopists and 42 anesthetists were involved in the procedures.
The logistic regression analysis identified female gender (OR=2.3), having the colonoscopy performed by a less
experienced endoscopist (OR=1.9), inadequate bowel preparation (OR=3.2) and a procedure lasting longer than
17.5 minutes (OR=1.6) as the main risk factors for complications. An ASA score of 2 carried a 50% risk reduction
(OR=0.5).
Discussion and conclusions: Our model showed that none of the variables relating to anesthesiological issues
influenced which procedures would prove difficult.
Background
A thorough colonoscopy is the endoscopist’s most
important goal, especially in screening programs. Failure
to complete a caecal intubation may be related to tech-
nical issues, the patient’s tolerance, and/or bowel pre-
paration. Various scientific societies have recommended
programs designed to improve the endoscopists’ perfor-
mance [1,2] and several bowel preparation methods
have been investigated to facilitate patient compliance
with the colon cleansing requirements [3].
Among all the factors capable of influencing the colono-
scopy success rate, increasing the patient’s tolerance by
means of a pharmacological sedation is the one that
enables the best results to be achieved. On the other hand,
such an approach has raised major concern regarding:
a) the generic risk relating to the use of sedatives, e.g.,
respiratory depression and cardiovascular complications,
compounding the specific risk of perforation or bleeding
with possible related medico-legal consequences[4]; b) the
involvement of different health professionals in the endo-
scopy room; c) the additional costs for monitoring devices
and ancillary personnel [5]. All these reasons make the use
of deep sedation debatable and many issues remain to be
solved or need further investigation [6,7].
Guidelines have been developed on the factors to con-
sider in order to guarantee a safe procedure, since
adverse events may depend not only on the endoscopist,
but also on the activities of the anesthetist, including the
preliminary risk assessment and patient monitoring [8,9].
The use of deep sedation with propofol in colonoscopy is
therefore a controversial issue because it demands careful
planning to maximize patients’ tolerance and minimize
their risks for diagnostic, or relatively simple therapeutic
procedures (such as polypectomy).
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Since the routine use of deep sedation with propofol is
relatively rare, only a few studies have addressed the corre-
lations between the factors that might contribute to ensur-
ing a risk-free, effective and tolerable colonoscopy.
The aim of our study was to investigate whether the cri-
tical situations encountered in the colonoscopy suite or
incomplete deep sedation-colonoscopies can be predicted
from the endoscopic or anesthesiological practices
involved and/or from the patient’s condition.
We considered a procedure as “difficult” if the colono-
scopy was incomplete or complicated for endoscopic rea-
sons, or for reasons relating to the anesthetist, or to
hemodynamic/respiratory changes in the patient, or if the
procedure required a dose of propofol higher than was
routinely used, with the risk of inducing general sedation.
Methods
We investigated the routine activity of an endoscopy
center at the Padova University teaching hospital, conse-
cutively enrolling in the study all patients who under-
went a colonoscopy under propofol sedation over a
period of six months.
Subject to patients’ informed written consent, their
clinical history was recorded to identify any anesthe-
siological or procedural risks, collecting data on: a)
non-gastrointestinal conditions; b) allergies or side
effects of previously-used anesthetics; c) ASA status.
Information was subsequently recorded on the comple-
teness of the colonoscopy, the propofol dosage used
and any adverse events on a case report form (CRF)
formulated specifically for the purposes of the study.
The health professionals responsible for compiling the
CRF were unaware that they were participating in the
study.
Classification of health professionals
The gastroenterologists and anesthetists involved in the
endoscopies were classified according to their level of
experience.
Gastroenterologists were grouped into three cate-
gories: 1) the “less experienced non-specialists” if they
had been performing endoscopies for less than 10 years;
2) the “more experienced non-specialists” if they had
been performing endoscopies for more than 10 years
but were not dedicated exclusively to endoscopic activ-
ities; and 3) the “highly-experienced specialists” if they
had been performing endoscopies for more than 10
years and handled at least four endoscopic sessions a
week.
Anesthetists were classified as “juniors” (if they had
practiced as anesthesiologists for less than 2 years),
“seniors” (2-5 years in practice) and “experts” (more
than 5 years in practice).
Propofol sedation
Before the colonoscopy, all patients received an initial
induction dose of propofol to induce a lethargic response
to oral stimuli and the absence of any corneal reflex.
During the procedure, propofol was titrated by the
anesthetist with intermittent boluses if patients showed
signs of more than mild discomfort and occasional gri-
macing, becoming agitated or clearly in pain at every
stage of the procedure.
Patient monitoring was started before sedation and
continued until patients recovered to check for any epi-
sodes of hypotension, hypoxemia, cardiac arrhythmia,
which were recorded in the CRF and treated pharmaco-
logically, where necessary.
The patients’ preparatory colon cleansing consisted in
their ingesting 4 liters of Macrogol solution at home the
day before the colonoscopy. Their bowel preparation
was classified as “adequate”, “with residual matter” or
“inadequate”.
Definition of a difficult procedure
A procedure was defined as being “difficult” when:
1. a total dose of propofol/kg 1 standard deviation
above the mean was administered;
2. the procedure met with complications, such as per-
foration or bleeding;
3. the colonoscopy was incomplete for technical reasons
(other than a patient’s inadequate bowel preparation);
4. there were adverse events relating to the sedation, e.
g., episodes of apnea, hypo- or hypertension, hypoxemia,
or cardiac arrhythmia.
Efficacy endpoints
The main efficacy endpoint was the completeness of the
colonoscopy, i.e. the identification of a normal cecum anat-
omy or ileocolic anastomosis, without the need for any
anesthesiological, pharmacological or manual intervention
to deal with respiratory or cardiocirculatory complications.
Colonoscopies stopped due to the diagnosis of a pathologi-
cal stenosis considered as completed procedures.
Hemodynamic monitoring data were used to deter-
mine the duration of the colonoscopy.
Statistical analysis
Summary statistics - mean values or percentages - were
compared by age group using the t-test or chi-square
test, respectively. Otherwise, analogous non-parametric
tests were used (the Wilcoxon rank-sum test or Fisher’s
exact test). Predictors of a “difficult procedure” were
investigated by multivariate stepwise (p-entry=0.15)
logistic regression analysis including all variables men-
tioned in table 3. The SAS statistical software, rel. 9.2
was used for the analysis.
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Results
During the study period, 617 colonoscopies were per-
formed under deep sedation in patients, mean 61.1 years
old (SD=13.2), 48.3% of them males.
Of the 14 endoscopists involved in these procedures, 5
were classified as with “less experienced” and performed
18.3% of the endoscopies, 6 were classified as “more
experienced non-specialists” and performed 59.5% of the
colonoscopies and the remaining 3 were classified as
“highly-experienced specialists” and performed 22.2% of
the procedures. Junior anesthetists (n=24) were involved
in 67.6% of the procedures, seniors (n=13) in 26.7% and
experts (n=5) in 5.7%.
The incomplete procedures (excluding those due to
inadequate bowel preparation) amounted to 6.8% (42/
617) (Table 1). There were 75 patients (12.2% of the
sample) with ASA scores of 3 or 4. The average dose of
propofol administered was 183±74.9 mg, while the aver-
age dose per kg of body weight was 2.6±1.2 mg/kg.
Tables 2 shows the characteristics of patients whose
procedures were and were not difficult, and Table 3
shows the results of the logistic regression analysis.
In all, 142 procedures (23%) were classified as difficult.
In addition to the procedures that were not completed
(42) and those incurring complications (40) during the
colonoscopy, 77 patients were given more than 3.8 mg/kg
of propofol. Fifteen patients experienced more than one
complication.At univariate level, we found a statistically
higher prevalence of female gender (66.2%), “less experi-
enced” endoscopists (26.8%), residual matter or inadequate
bowel preparation (26.1% and 11.2%, respectively) and an
ASA score of 1 (46.5%) in the group with difficult proce-
dures, this group was also statistically younger (mean 58.8
years) and their procedure took longer (26.9 minutes).
The logistic regression analysis identified female gen-
der (OR=2.3), having the colonoscopy performed by a
less experienced endoscopist (OR=1.9), inadequate
bowel preparation (OR=3.2) and a procedure lasting
longer than 17.5 minutes (OR=1.6) as the main risk fac-
tors for complications. On the other hand, an ASA
score of 2 carried a 50% risk reduction (OR=0.5). The
logistic model had an area under the curve (ROC) of
70%. None of the other variables contributed to the pre-
dictive power of the model.
Discussion and conclusion
It has been demonstrated that cardiorespiratory compli-
cations during a colonoscopy may be associated with
anesthesiological practices (especially if sedation is kept
constant using the simple propofol boli technique) due
to an excessive dose of drug, inadequate patient moni-
toring, and/or an excessively rapid induction of sedation
[10,11].
Our study shows that difficulties encountered during
colonoscopy procedures cannot be explained, however,
by variables relating to anesthesiological activity during
deep sedation with propofol. There are also technical
issues, already identified in the pre-propofol era [12],
that contribute to complicating a colonoscopy.
Analyzing our black box warnings on deep sedation with
propofol highlighted that the endoscopist’s experience,
bowel preparation, and female gender are the factors that
correlate with difficult procedures in patients sedated up
to level 4 of the spectrum of continuum of sedation, as
defined by the American Society of Anesthesiology. Inter-
ventions to restore adeguate airway function or ventilation
are likely to be needed for this type of patient. Unsatisfac-
tory bowel preparation, female gender, age and constipa-
tion were identified by Won Ho Kim [13] as determinants
of difficulties encountered in performing colonoscopies,
while Doger [14] found that gender, age and the endosco-
pist’s experience contributed to the duration of the proce-
dure. These two studies report results similar to ours,
though their patients were not administered propofol.
Some studies have tried to find strategies for contain-
ing the anesthesiological risk by reducing the propofol
dosage, without increasing the patient’s discomfort,
using either a combination of drugs [15] or a patient-
controlled infusion [16]. Our study focused instead on
Table 1 Characteristics of the endoscopies.
Characteristics Values (n=617)
Complete colonoscopy 93.2% (575/617)
Incomplete colonoscopy 6.8%(42/617)
technical reasons 76.2% (32/42)
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adverse events and their causes, correlating these with
the total dose of propofol administered by the anesthe-
tist on the basis of evidence of the patient’s pain, a
situation that can lead to over-sedation using the drug
titers adopted by the anesthesist. That is why we
included the use of a dose of propofol more than one
standard deviation above the mean among the “difficult
procedures”. Since a relationship has been shown
between propofol dosage and cardiovascular events
[10,17], high doses can be seen as indicators of situa-
tions at risk. Critical situations can crop up in the endo-
scopy room due to the need to take action to maintain
the patient’s vital parameters. The average propofol dose
used in our study was 2.8 mg/kg, which is higher than
in previous studies [15,18] but analysis indicated that
the anesthetist’s role had no influence on the rate of dif-
ficult procedures. One explanation for this may have to
do with the endoscopist finding it difficult to complete
quickly and as painlessly as possible due to inexperience
or the need to perform a polypectomy.
The interaction between propofol dosage and the
patient’s conditions was also studied, revealing negative
effects [8]. In our multivariate analysis, an ASA score of 2
tended to protect against occurrence of difficulties; Heuss
found [18] that the ASA factor has little influence on the
secondary effects of sedation and there is only a limited
risk of oxygen desaturation for ASA levels III and IV. The
only patient-related variable affecting the rate of difficult
procedures was gender, as in several other studies on “dif-
ficult” colonoscopies in the pre-propofol era [19,20].
Table 2 Distribution of the main characteristics by procedure (difficult vs routine).
Difficult procedure (n=142) Routine procedure (n=475) P value
Gender (females) 66.2% 47.4% <0.0001
Mean age±SD 58.8±14.6 61.8±12.6 0.03
Endoscopists 0.014
less experienced 26.8% 15.8%
more experienced non-specialists 52.1% 61.7%
highly experienced specialists 21.1% 22.5%
Current diseases
Allergy 20.4 22.1 0.72
Heart 16.9 15.2 0.60
Liver 7.7 5.3 0.30
Kidney 2.8 4.6 0.47
Thyroid 5.6 5.7 1.00
Polypectomy 14.8 16.0 0.79
Duration of colonoscopy (minutes)
mean±SD 26.9±14.2 22.0±10.2 0.0002
range 5-85 2-65
Bowel preparation
adequate 62.7% 77.3% <0.0001












Females 2.312 1.528-3.498 <0.0001
ASA=1 1
ASA=2 0.539 0.344-0.844 0.0070















Duration of procedure ≥17.5 1.633 1.050-2.538 0.0294
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One limit of our study is the lack of a control group
undergoing colonoscopy without sedation, but we feel -
given that all the variables that we considered were
related to the endoscopic techniques, and in the light of
comparisons drawn with other reports on colonoscopy
performed without propofol - that even when patients
are under deep sedation, the expertise of the endosco-
pist is still more important to the success of a colono-
scopy than is the role of the anesthetist. Our study was
designed on the strength of a discussion on endoscopic
sedation policy issues, developed within the American
Gastroenterology Association [21].
We did not consider aspects relating to the costs of the
sedation procedure, since these are strongly influenced by
local conditions within different public health systems and
not easy to extend to an international scenario. It was
recently pointed out that using propofol at endoscopy cen-
ters facilitates patient turnover [22]. Unfortunately, we are
unable to provide information on our patients’ recovery
and their compliance with the procedure because these
data are not routinely collected at our center. We pre-
ferred to keep to the data collected in daily practice to
avoid influencing the endoscopist’s routine and giving rise
to any Hawthorne effect.
We also believe that the fact we used no pumps for drug
infusion (leaving the propofol dosage up to the anesthetist)
and that we assessed the activity of anesthetists and endos-
copists with different levels of expertise constitutes an
advantage in terms of the general applicability of our find-
ings. These elements probably influenced endoscopic per-
formance: our 93.2% success rate (94.8% if incomplete
procedures due to inadequate bowel preparation are disre-
garded) is definitely higher than at other endoscopy cen-
ters where deep sedation is not used [23], getting closer to
the target indicated for screening examinations [24].
Our findings could be compared (given their geographi-
cal and organizational affinity) with those reported by
Fasoli [25], showing that propofol helps to improve the
performance of less experienced endoscopists. We, indeed,
confirm Karan’s comment [8] that a prolonged procedure
represents further duties for the anesthesiologist; and
according to Ju-Mei [16] the duration of the colonoscopy
and the patient’s pain are reasons for the use of higher
doses of propofol.
It has also been said that cardiopulmonary events
account for about half of the adverse events during
endoscopies [24]. In our series, we recorded one perfora-
tion, one hemorrhage caused by polypectomy and 36 car-
diorespiratory event. This number is elevated because we
considered not only events requiring tracheal intubation
or cardiopulmonary resuscitation (which never proved
necessary in our series), but also events requiring airway
manipulation or pharmacological intervention by health
professionals other than the endoscopist, involved in the
procedure, since this obviously interfered with the endo-
scopic procedure proper. However, the 5% adverse events
rate is comparable with the one recorded by Rex [17],
who also showed that trained nurses and endoscopists
can administer propofol safely for endoscopy. Our study,
referred to an anesthesiologist-based standard endoscopic
sedation, shows that adverse events always have to do
with the endoscopic techniques, whereas the anesthetist’s
experience had a negligible influence. Our findings seem
to contradict any concern [26] that the use of anesthe-
siologists during colonoscopy has the potential to trans-
form endoscopic practice.
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